and Vietnam. Since 2020, the global SMA treatment landscape has progressed, with three treatments now approved, according to Novartis. Along with Zolgensma – which made its debut in 2019 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback